During today's trading session, Ipca Laboratories experienced a price increase, with its shares rising by 2.09% to Rs 1,418.5 apiece. This movement positions Ipca Laboratories among the top gainers in the NIFTY MIDCAP 150 index.
Financial Performance Overview
Ipca Laboratories' financial performance provides context to its recent stock activity. Key financial data includes:
Consolidated Revenue:
Consolidated Net Profit:
Consolidated EPS (Earnings Per Share):
Annual Financial Highlights
The annual consolidated financials provide a broader view of Ipca Laboratories' performance:
| Year | Revenue (Rs Crores) | Net Profit (Rs Crores) | EPS (Rs) | BVPS (Rs) | ROE (%) | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 5,419.99 | 1,148.84 | 45.01 | 371.79 | 24.24 | 0.05 |
| 2022 | 5,829.79 | 910.95 | 34.85 | 219.51 | 16.09 | 0.14 |
| 2023 | 6,244.32 | 491.93 | 18.58 | 233.16 | 8.06 | 0.25 |
| 2024 | 7,705.04 | 529.21 | 25.82 | 304.57 | 8.64 | 0.22 |
| 2025 | 8,939.59 | 787.53 | 29.08 | 273.88 | 10.61 | 0.19 |
The company has demonstrated consistent revenue growth over the past five years, with revenue increasing from Rs 5,419.99 Crores in 2021 to Rs 8,939.59 Crores in 2025. Net profit has fluctuated, with a high of Rs 1,148.84 Crores in 2021 and a recent figure of Rs 787.53 Crores in 2025. The debt-to-equity ratio has remained relatively stable, indicating a balanced financial structure.
Market Sentiment
According to Moneycontrol's analysis, the market sentiment for Ipca Laboratories is very bearish as of June 12, 2025.
Ipca Laboratories' stock performance reflects its position within the NIFTY MIDCAP 150 index, with today's gains contributing to its overall market presence.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
